Rural opioid treatment program patient perspectives on take-home methadone policy changes during COVID-19: a qualitative thematic analysis

BACKGROUND: In the United States, methadone for opioid use disorder (OUD) is highly regulated. Federal agencies announced guidelines in March 2020 allowing for relaxation of take-home methadone dispensing at opioid treatment programs (OTPs) to improve treatment access and reduce COVID-19 transmissio...

Descripción completa

Detalles Bibliográficos
Autores principales: Levander, Ximena A., Hoffman, Kim A., McIlveen, John W., McCarty, Dennis, Terashima, Javier Ponce, Korthuis, P. Todd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665717/
https://www.ncbi.nlm.nih.gov/pubmed/34895346
http://dx.doi.org/10.1186/s13722-021-00281-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665717/
https://www.ncbi.nlm.nih.gov/pubmed/34895346
http://dx.doi.org/10.1186/s13722-021-00281-3

Ejemplares similares